2016 has proved to be yet another eventful year for the pharmaceutical industry. As predicted by many analysts and market watchers, pharmaceutical businesses continued to move at an accelerated pace to outsourcing as they sought to reduce costs whilst searching for that elusive ‘innovative’ spark. The increase in outsourcing naturally led to more collaboration, and…